Why is it in the news?
CDSCO approved generic semaglutide injection for manufacture and marketing in India.
Category: Science and Technology
Important Points:
● Belongs to GLP-1 receptor agonists (GLP-1 RAs)
● Mimics GLP-1 hormone released after eating
● Increases insulin production and lowers blood sugar
● Used to treat type 2 diabetes
● Reduces risk of heart attack and stroke in diabetic patients
● Used in obesity and weight-related conditions
● Helps reduce risk of kidney disease progression
● Approved for manufacturing by Natco Pharma in India